Sleep is a fundamental physiologic process vital for cognition, cardiovascular function, immune function, glucose metabolism, hormone regulation, and recovery from illness. Acute hospitalization, whether in an inpatient ward or intensive care unit (ICU), contributes to sleep loss and decrements in restorative N3 and rapid eye movement (REM) sleep. 1, 2 This loss of restorative sleep is believed to precipitate delirium, 3 a risk factor for adverse in-hospital [4] [5] [6] and postdischarge outcomes, 7-10 along with long-term consequences such as posttraumatic stress disorder and posthospital syndrome.
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Several factors contribute to poor inpatient sleep quality (see ►Fig. 1). Preexisting sleep disorders, including sleep disordered breathing (SDB), contribute to chronic and acute sleep deprivation in patients admitted to the hospital. Moreover, after hospital admission, environmental factors such as noise and light, patient care activities, and medications contribute to acute sleep deprivation and circadian disruption. 12 Despite this knowledge, significant strides have not been made to improve sleep in hospitalized patients. Early recognition and management of undiagnosed SDB and modifiable disruptors of sleep in the hospital setting require multidisciplinary coordination of care, and may improve patient outcomes. In this article, we discuss sleep in the hospital setting, as it pertains to critically ill and noncritically ill inpatients, with an additional focus on patients with existing or undiagnosed SDB.
Normal Human Sleep
Sleep is a periodic, reversible state of cognitive and sensory disengagement from the external environment. Normal overnight sleep in adults typically lasts 7 to 9 hours and consists of four to six 90-to 100-minute periods during which nonrapid eye movement (NREM) and REM sleep alternate in a cyclical fashion (►Fig. 2, "normal adult"). 13 Wake after sleep onset is minimal, comprising <5% of the overnight sleep period.
14 NREM sleep is comprised of stages N1, N2, and N3, which grossly correlate to depth of sleep. N1 comprises 2 to 5% of a total night's sleep and is characterized by low amplitude, mixed frequency electroencephalogram (EEG) waves. Given a low arousal threshold during N1, this stage is sometimes referred to as "light sleep" and is believed by some experts to represent the transition from wake to sleep, with true sleep not occurring until N2.
14 Following N1 is N2 sleep, which comprises 45 to 55% of a total night's sleep and is characterized by stereotypic EEG findings of K-complexes and sleep spindles. 15 N3 follows N2, comprises 20% of a night's sleep, and is characterized by low frequency, high amplitude delta waves on EEG; N3 is otherwise known as slow wave sleep (SWS). Typically, N3 transitions back to N2 before proceeding to REM sleep, which occupies 20 to 25% of the total sleep period and is made up of tonic and phasic REM. Tonic REM is characterized by skeletal muscle atonia and low voltage, high amplitude, mixed frequency-α, and "saw-tooth" theta waves on EEG. Phasic REM occurs in short bursts intruding intermittently on tonic REM periods, and is characterized by autonomic variability and somatic muscle twitches.
14,15

Sleep Measurement
The gold standard for sleep measurement is polysomnography (PSG), consisting of EEG, electrooculography, electromyelography, electrocardiography, respiratory flow and effort measurement, pulse oximetry, and a microphone; this allows for the analysis of brain activity, eye movement, muscle, cardiac, and respiratory activity, oxygen saturation, and noise (i.e., snoring), respectively. Because PSG is cumbersome and expensive, especially in the inpatient setting, alternative strategies are available to measure sleep. Actigraphy, which involves a wrist watch type device to detect patient motion, provides a practical and noninvasive tool for sleep measurement but has limited use in the inpatient setting, as it can overestimate sleep in inactive, mostly motionless awake hospitalized patients. NREM sleep is associated with progressive decrements in minute ventilation and a 3 to 7 mm Hg increase in paCO 2 . In addition, increased parasympathetic tone during NREM results in decreased blood pressure, heart rate, and systemic vascular resistance. 27 Autonomic variability during REM leads to bursts of vagal activity with bradyarrhythmias and sinus pauses during tonic REM, and increased sympathetic activity with increased heart rate and blood pressure during phasic REM.
28
Growth hormone (GH) and prolactin, anabolic hormones necessary for cell differentiation and proliferation, follow the 57, 63 From the earliest days of critical care, excessive noise has been considered a significant source of stress, anxiety, and negative psychological outcomes in hospitalized patients.
64-77
More recently, noise has been implicated as a common disruptor of sleep in the ICU and general wards. Although we may need to reconsider our ability to eliminate background machine noise, a reasonable first step toward patient sleep improvement may be to address sound peaks and avoidable disturbing sounds such as staff conversations and unnecessary equipment alarms. notably higher in the setting of coronary artery disease (CAD), 125 diabetes, 126 and stroke. 127, 128 Central sleep apnea (CSA) and mixed apnea syndromes also occur and are particularly common in patients with systolic and diastolic heart failure (HF). Treatment of SDB is often hampered by underrecognition; approximately 40% of patients remain undiagnosed. 129 In addition, despite well-documented improvement in a variety of important health outcomes, compliance with positive airway pressure (PAP) therapy of patients with OSA remains poor, at approximately 50%.
130,131
The presence of OSA in an inpatient carries increased risk for complications and poor outcomes during the hospitalization and beyond. For example, in a retrospective cohort study of >250,000 patients at 347 U.S. hospitals, 6.2% of patients hospitalized with pneumonia had OSA and were twice as likely to need invasive ventilation, four times more likely to receive noninvasive ventilation, and used more healthcare resources.
132 Therefore, suspicion for underlying OSA in a hospitalized patient presents a pivotal opportunity for diagnosis and treatment, and prevention of adverse outcomes. Below we discuss specific disease populations at elevated risk. 
Cardiovascular Disease and Sleep Disordered Breathing
141-143
SDB has been observed in 50 to 80% of HF patients with and without preserved ejection fraction.
144-148 CSA including
Cheyne-Stokes respiration is also common in patients with HF, and is associated with increased age, male gender, hypocapnia, coexisting atrial fibrillation, and use of diuretics. 149 A randomized controlled trial involving patients with systolic HF suggested that, as compared with medical management alone, 1 month of CPAP improved oxygenation, decreased daytime systolic blood pressure, heart rate, and afterload, and improved left ventricular ejection fraction from 25 to 34%.
150
Recognition of CSA in HF warrants consideration of more advanced noninvasive modes of ventilation such as bilevel PAP and adaptive servo-ventilation. 151, 152 Patients with HF
and suspected OSA or CSA should be referred for a sleep study and PAP titration.
Cerebrovascular Disease and Sleep Disordered Breathing
As with CAD, cerebrovascular accidents (CVA) and OSA are highly associated. OSA is an independent risk factor for initial and recurrent stroke and is associated with increased length of hospital stay and 6-month mortality following a stroke. [153] [154] [155] In addition, development of SDB is common following CVA, with rates ranging from 60 to 96%.
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Factors influencing SDB severity post-CVA include the site and severity of brain ischemia, post-CVA neurological function, and medications. and general medical settings, 186 sleep promotion continues to gain attention as part of efforts to understand and improve patients' recovery from illness and posthospital outcomes. Paramount to the success and sustainability these hospitalbased efforts is the involvement of a multidisciplinary team of stakeholders, employment of established quality improvement methods, and consideration of local barriers to implementation. 3 Future hospital-based sleep promotion research should focus on the added benefit of interventions to assess and treat SDB, important associations of sleep improvement and short-and long-term cognitive and physical outcomes, and strategies for long-term intervention sustainability.
Conclusion
Sleep deprivation and circadian disruption is common in inpatients recovering from acute medical illness, especially to the ICU setting. Poor inpatient sleep quality is the result of myriad factors including preexisting sleep disorders, SDB, environmental noise and light, patient care activities, MV, and medications. Patients with SDB represent a particularly vulnerable population for whom hospital admission should serve as an opportunity to aggressively diagnose and treat SDB. Recognition and mitigation of SDB and other modifiable factors affecting sleep quality in the hospital setting must involve a multidisciplinary approach, and may profoundly impact acute and chronic patient outcomes.
